|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy ofeverolimus in advanced renal cell carcinoma : a double,Blind randomised, placebo controlled phase HI trial显示文摘 | Motzer R J Escudier B Oudard S | 2008 | Lancet2008，372，44： | 1 |
| 2 | Multicenter randomized phase Ⅱ study of two schedules of docetaxel,estramustine,and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer显示文摘 | Oudard S Banu E Beuzeboc P | 2005 | J Clin Oncol2005，23，15： | 1 |
| 3 | Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy:new paradigm from a large phase Ill trial with shark cartilage extract AE 941 显示文摘 | Escudier B Choueiri T K Oudard S | 2007 | J Urol2007，178，5： | 1 |
| 4 | Prednisone plus cabazitaxel or mitoxantrone for metastatic castration- resistant prostate cancer progressing after docetaxel treat- ment : a randomised open-label trial 显示文摘 | de Bono J S Oudard S Ozguroglu M | 2010 | Lancet2010，376，9747： | 1 |
| 5 | Phase 3 Trial of everolimus for metastatic renal cell carcinoma 显示文摘 | MOTZER RJ ESCUDIER B OUDARD S | 2010 | Cancer2010，116，18： | 1 |
| 6 | Cabazitaxel formetastatic castration-resistant prostate cancer progressingafter docetaxel treatment: the TROPIC study in France 显示文摘 | Pouessel D Oudard S Gravis G | 2012 | Bull Cancer2012，99，78： | 1 |
| 7 | Denosumab and bone metastasis - free survival in men with nonmetastatic castration - resistant pros- tate cancer:exploratory analyses by baseline prostate - specific anti- gen doubling time显示文摘 | Smith M R Saad F Oudard S | 2013 | J Clin Oncol2013，31，30： | 1 |
| 8 | Impact of cabazitaxel on2-year survival and palliation of tumour-related pain in menwith metastatic castration-resistant prostate cancer treated inthe TROPIC trial 显示文摘 | Bahl A Oudard S Tombal B | 2013 | Ann Oncol2013，24，9： | 1 |
| 9 | Efficacy of everolimus in advanced renal cell carcinoma:a double-blind, randomised,placebo-controlled phaseⅢtrial显示文摘 | MOTZER R ESCUDIER B OUDARD S | 2008 | Lancet2008，372，9637： | 1 |
| 10 | Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase Ⅲ trial with shark cartilage extract AE 941显示文摘 | ESCUDIER B CHOUEIRI TK OUDARD S | 2007 | J Urol2007，178，5： | 1 |
| 11 | Anaphylactic reaction after a first filgrastim(granulocyte-colony stimulating fac-tor)injection显示文摘 | Batel-Copel L Mommeja-Matin H Oudard S | | 0，，： | 1 |
| 12 | Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941 显示文摘 | Escudier B Choueiri T K Oudard S | 2007 | J Urol2007，178，5： | 1 |
| 13 | Efficacy ofeverolimus in advanced renal cell carcinoma: a double- blind, randomised, placebo-controlled phase HI trial 显示文摘 | Motzer RJ Escudier B Oudard S | 2008 | lancet2008，372，9637： | 1 |
| 14 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, ran- domised, placebo-controlled phase Ⅲ trial显示文摘 | MOTZER RJ ESCUDIER B OUDARD S | 2008 | Lancet2008，372，9637： | 1 |
| 15 | Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms 显示文摘 | Legrier ME Oudard S Judde JG | 2007 | Br J Cancer2007，96，2： | 1 |
| 16 | Phase 3 trialof everoiiimis for metastatic renal cell carcinoma 显示文摘 | MOTZKK KJ ESCUDIER B OUDARD S | 2010 | Cancer2010，116，18： | 1 |
| 17 | Prednisone plus caba- zitaxcl or mitoxantrone for metastatic castration-resistant pros-tate cancer progressing after docetaxel treatment: a randomized open-label trial 显示文摘 | de Bono JS Oudard S Ozguroglu M | 2010 | Lancet2010，376，9747： | 1 |
| 18 | Efficacy ofeverolimus in advanced renal cell carcinoma : a (ioui)le-i)lin显示文摘 | MOTZEK KJ ESCUDIER li OUDARD S | 2008 | Lancet2008，372，9637： | 1 |
| 19 | Efficacy of everolimus in ad- vanced renal cell carcinoma: a double-blind, randomised, placebo-con- trolled phase Ⅲ trial 显示文摘 | Motzer R J Escudier B Oudard S | 2008 | Lancet2008，372，： | 1 |
| 20 | Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors显示文摘 | Motzer RJ Escudier B Oudard S | 2010 | Cancer2010，116，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员